Home LiteratureArticle Details
PMID: 14576730 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Comparative analysis of T-cell receptor gene rearrangements at diagnosis and relapse of T-cell acute lymphoblastic leukemia (T-ALL) shows high stability of clonal markers for monitoring of minimal residual disease and reveals the occurrence of second T-ALL.

Leukemia ·Vol. 17 ·No. 11 ·2003-11-00 ·Pages 2149-56

Szczepański T, van der Velden VH, Raff T, Jacobs DC, van Wering ER, Brüggemann M, Kneba M, van Dongen JJ

Abstract

A total of 28 children and nine adults with relapsed T-ALL were analyzed for the configuration of their T-cell receptor (TCR) and TAL1 genes at diagnosis and relapse to evaluate their stability throughout the disease course. A total of 150 clonal TCR and TAL1 gene rearrangements were identified in the 37 patients at diagnosis. In 65% of cases all rearrangements and in 27% of cases most rearrangements found at diagnosis were preserved at relapse. Two children with unusually late T-ALL recurrences displayed completely different TCR gene rearrangement sequences between diagnosis and relapse. This indicates that a proportion of very late T-ALL recurrences might represent second T-ALL. Specifically, 88% of clonal rearrangements identified at diagnosis in truly relapsed T-ALL were preserved at relapse. This is significantly higher as compared to previously studied precursor-B-ALL ( approximately 70%). Thus, from biological point of view, immunogenotype of T-ALL is more stable as compared with precursor-B-ALL. The overall stability of TCR gene rearrangements was higher in adult T-ALL (97%) than in childhood T-ALL (86%). Based on the stability of TCR gene rearrangements, we propose a strategy for PCR target selection (TCRD+TAL1 --> TCRB --> TCRG), which probably allows reliable minimal residual disease detection in all T-ALL patients.

MeSH Terms
Adult Biomarkers, Tumor Bone Marrow Cells/immunology Child Gene Rearrangement, T-Lymphocyte Humans Leukemia-Lymphoma, Adult T-Cell/genetics,immunology Neoplasm, Residual/diagnosis,genetics,immunology Polymerase Chain Reaction/methods Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics,immunology,pathology Recurrence
Chemicals
Biomarkers, Tumor
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Szczepański T
Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
van der Velden V H J
Raff T
Jacobs D C H
van Wering E R
Brüggemann M
Kneba M
van Dongen J J M
Article Info
Journal
Leukemia
Abbr.
Leukemia
ISSN
0887-6924
Published
2003-11-00
Pages
2149-56
Language
English
Region
England
NLM ID
8704895
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com